Suppr超能文献

经CT引导下经皮穿刺针活检诊断为髓过氧化物酶抗中性粒细胞胞浆抗体(MPO-ANCA)阳性的胸膜实质纤维弹性组织增生症

Pleuroparenchymal fibroelastosis with positive MPO-ANCA diagnosed with a CT-guided percutaneous needle biopsy.

作者信息

Yamakawa Hideaki, Oda Tsuneyuki, Baba Tomohisa, Ogura Takashi

机构信息

Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.

出版信息

BMJ Case Rep. 2018 Feb 24;2018:bcr-2017-223287. doi: 10.1136/bcr-2017-223287.

Abstract

A 67-year-old woman was referred to our hospital because of gradually increasing dyspnoea on exertion for 6 months. Chest CT scan showed subpleural parenchymal fibrotic opacities with traction bronchiectasis in the bilateral upper lung fields. Serum rheumatoid factor and myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) were positive. There was no evident reason to suspect connective tissue disease such as ANCA-associated vasculitis or rheumatoid arthritis. We performed a CT-guided percutaneous needle biopsy of the subpleural lesion that showed slight uptake on the fluorodeoxyglucose-positron emission tomography (FDG-PET) CT scan. This specimen showed subpleural fibrosis as evidenced by an abnormal increase of elastic tissue and minimal collagen deposition, which indicated pleuroparenchymal fibroelastosis (PPFE). Although PPFE can be associated with a variety of causes, its association with MPO-ANCA is unknown. A CT-guided transthoracic lung biopsy caused no adverse events and was useful in the diagnosis of PPFE in our patient.

摘要

一名67岁女性因劳力性呼吸困难逐渐加重6个月而转诊至我院。胸部CT扫描显示双侧上肺野胸膜下实质纤维化混浊伴牵拉性支气管扩张。血清类风湿因子和髓过氧化物酶-抗中性粒细胞胞浆抗体(MPO-ANCA)呈阳性。没有明显理由怀疑存在诸如ANCA相关血管炎或类风湿关节炎等结缔组织病。我们对胸膜下病变进行了CT引导下经皮针吸活检,该病变在氟脱氧葡萄糖-正电子发射断层扫描(FDG-PET)CT上显示有轻微摄取。该标本显示胸膜下纤维化,表现为弹性组织异常增加和胶原沉积极少,提示胸膜肺实质纤维弹性组织增生症(PPFE)。虽然PPFE可与多种病因相关,但其与MPO-ANCA的关联尚不清楚。CT引导下经胸肺活检未引起不良事件,对我们患者的PPFE诊断很有帮助。

相似文献

1
Pleuroparenchymal fibroelastosis with positive MPO-ANCA diagnosed with a CT-guided percutaneous needle biopsy.
BMJ Case Rep. 2018 Feb 24;2018:bcr-2017-223287. doi: 10.1136/bcr-2017-223287.
2
[Idiopathic pleuroparenehymal fibroelastosis: report of one case and review of literature].
Zhonghua Jie He He Hu Xi Za Zhi. 2019 Nov 12;42(11):852-857. doi: 10.3760/cma.j.issn.1001-0939.2019.11.014.
3
Lower-lobe predominant pleuroparenchymal fibroelastosis.
Pathol Int. 2019 Sep;69(9):536-540. doi: 10.1111/pin.12827. Epub 2019 Jul 4.
5
Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: A retrospective multicenter study.
Respir Med. 2017 Dec;133:1-5. doi: 10.1016/j.rmed.2017.11.003. Epub 2017 Nov 6.
6
Pleuroparenchymal Fibroelastosis of the Lung: A Review.
Arch Pathol Lab Med. 2016 Aug;140(8):849-53. doi: 10.5858/arpa.2015-0166-RS.
7
Overcoming the challenges of a misdiagnosed rare lung disease - idiopathic pleuroparenchymal fibroelastosis.
Monaldi Arch Chest Dis. 2023 Aug 2;94(2). doi: 10.4081/monaldi.2023.2632.
10
Idiopathic pleuroparenchymal fibroelastosis (PPFE) - A case study of a rare entity.
Rev Port Pneumol (2006). 2017 Nov-Dec;23(6):352-355. doi: 10.1016/j.rppnen.2017.06.006. Epub 2017 Aug 3.

引用本文的文献

1
Korean Guidelines for the Diagnosis and Management of Interstitial Lung Disease: Other Forms of Interstitial Lung Disease.
Tuberc Respir Dis (Seoul). 2025 Jul;88(3):454-476. doi: 10.4046/trd.2024.0181. Epub 2025 Mar 13.
2
[Pleural Metastasis of Lung Cancer Combined with Pleuroparenchymal Fibroelastosis: A Case Report].
J Korean Soc Radiol. 2024 May;85(3):631-636. doi: 10.3348/jksr.2023.0024. Epub 2024 Mar 8.
3
Pleuroparenchymal Fibroelastosis. A Review of Clinical, Radiological, and Pathological Characteristics.
Ann Am Thorac Soc. 2019 Nov;16(11):1351-1359. doi: 10.1513/AnnalsATS.201902-181CME.
4
Pleuroparenchymal fibroelastosis (PPFE) treated with lung transplantation and review of the literature.
BMJ Case Rep. 2019 Apr 20;12(4):e229402. doi: 10.1136/bcr-2019-229402.
5
Pleuroparenchymal fibroelastosis as a histological background of autoimmune diseases.
Virchows Arch. 2019 Jan;474(1):97-104. doi: 10.1007/s00428-018-2473-3. Epub 2018 Oct 16.

本文引用的文献

2
Two cases of pleuroparenchymal fibroelastosis diagnosed with transbronchial lung biopsy.
Respir Med Case Rep. 2016 Jul 18;19:71-3. doi: 10.1016/j.rmcr.2016.07.008. eCollection 2016.
3
Pleuroparenchymal fibroelastosis: role of high-resolution computed tomography (HRCT) and CT-guided transthoracic core lung biopsy.
Insights Imaging. 2016 Feb;7(1):155-62. doi: 10.1007/s13244-015-0448-3. Epub 2015 Nov 17.
5
Pleuroparenchymal fibroelastosis from a consecutive database: a rare disease entity?
Eur Respir J. 2015 Apr;45(4):1183-6. doi: 10.1183/09031936.00214714. Epub 2015 Feb 19.
6
Antineutrophil cytoplasmic antibody-positive conversion and microscopic polyangiitis development in patients with idiopathic pulmonary fibrosis.
BMJ Open Respir Res. 2015 Jan 9;2(1):e000058. doi: 10.1136/bmjresp-2014-000058. eCollection 2015.
7
Pleuroparenchymal Fibroelastosis: Its Clinical Characteristics.
Curr Respir Med Rev. 2013 Jun;9(4):299-237. doi: 10.2174/1573398X0904140129125307.
9
Interstitial pneumonia associated with MPO-ANCA: clinicopathological features of nine patients.
Respir Med. 2012 Dec;106(12):1765-70. doi: 10.1016/j.rmed.2012.08.024. Epub 2012 Sep 17.
10
Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study.
Rheumatology (Oxford). 2011 Nov;50(11):2035-43. doi: 10.1093/rheumatology/ker236. Epub 2011 Aug 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验